Lupin Limited (Lupin) the Indian Global pharmaceuticals major announced that the company will launch Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States, which got approval from the U.S. byAbbreviated New Drug Application (ANDA).
This is a bioequivalent product of Edarbi® produces byAzurity Pharmaceuticals,...
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Eli Lilly and Company (Lilly) has successfully acquired 4E Therapeutics, a Texas-based neuroscience company pioneering next-generation treatments for chronic pain. The acquisition integrates 4E...
On 18th June Pfizer Inc. (NYSE: PFE) the American Pharmaceuticals major announced that Dave Denton currently working as Chief Financial Officer (CFO) will step down from his current role and leave the company on...
India’s pharmaceutical sector has witnessed remarkable growth over the past 12 years, driven by initiatives aimed at expanding healthcare access, strengthening domestic manufacturing, and...